Australia's largest stock trading and investment forum Australia's #1 stock forum

GSS

Click for more information

0.69%

71.5¢ genetic signatures limited

I think you might be right... the revenue looks a little bit...

First 16 Last

Share
Profile

Follow
dunnomuch

2,226 Posts.

910

23/10/20

12:03

Post #: 48332378
Share

Originally posted by Al.: ↑

My estimate over the next 2 yes the company will generate somewhere in the order of $100m in cashflow - which when invested to establish the other lines of diagnostics will firmly establish itself in the ASX200.

STI tests are extremely hit and miss with multiple swabs blood tests to get 3 or 4 results from 12-15 that could be done in one GSS swab. STI’s are going through the roof - the data correlated with a sharp increase following app’s such as tinder - not to mention pornhub being the 15th most visited website and in the top sites across the world promoting unprotected sex, much like the Covid parties held in US colleges when people didn’t believe the risks associated with covid. These factors are accelerating the spread of STI. Unfortunately these factors are not going away

Expand

I think you might be right... the revenue looks a little bit unbelievable in terms of it's rate of growth. I bought a few of these yesterday just to put them on my screen so I have to look at who they are and the more I look, the more I like! Chris Abbott is the major shareholder, that's a massive vote of confidence in the commercial acumen of the board.

What an interesting company indeed...

GSS Price at posting: $1.99 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

AZY

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

There are more pages in this discussion • 9 more messages in this thread...

First 16 Last

Add GSS (ASX) to my watchlist

(20min delay)
Last 71.5¢		Change -0.005(0.69%)		Mkt cap ! $163.1M

Open	High	Low	Value	Volume
71.5¢	71.5¢	71.5¢	$2.86K	4K

Buyers (Bids)

No.	Vol.	Price($)
2	3864	71.0¢

Sellers (Offers)

Price($)	Vol.	No.
71.5¢	816	1

View Market Depth

No.	Vol.	Price($)
1	2000	0.715
1	1864	0.710
1	7000	0.705
4	49588	0.700
2	18500	0.695

Price($)	Vol.	No.
0.720	1299	1
0.725	14363	1
0.730	10000	1
0.735	5000	1
0.740	6000	1

Last trade - 10.12am 10/07/2024 (20 minute delay)

GSS (ASX) Chart

SPONSORED BY